New Year, New Us: Get A Sneak Peak At Our New Site

Prostate Cancer and Cardiovascular Disease


What clinical factors influence treatment decisions for localized prostate cancer?

Moderators: Tia Higano, MD & Neil Fleshner, MD, MPH

This session will cover management issues in patients with newly-diagnosed localized disease.

  1. How do I advise my patient of the best choice individually?
    Derya Tilki, MD
    Professor of Urology
    Martini-Klinik Prostate Cancer Center and Department of Urology
    University Hospital Hamburg-Eppendorf Hamburg, Germany
  2. Role of ADT as adjuvant therapy in radiation treatment with curative intention
    Paul Nguyen, MD
    Professor of Radiation Oncology
    Harvard Medical School, USA
  3. Which screening tests and initial treatments are needed to prevent CVD progression?
    Chris Plummer, MD
    Consultant Cardiologist
    Newcastle’s Freeman Hospital, UK
  4. Discussion/question and answer, 15 minutes

Please note: Moderators and Speakers are subject to change

Topics to cover in this session:

  • Factors influencing choice of local treatment (surgery vs. radiotherapy vs. active surveillance vs. watchful waiting) of newly diagnosed prostate cancer (age, co-morbidities, including CV, etc).
  • Role of hormonal suppression in conjunction with radiation therapy
  • Systemic effects of hormonal based therapy
    • GnRH agonist vs. antagonist
    • CVD optimization at the onset of cancer treatment
  • Indications for statins, aspirin, SGLT2 inhibitors or metformin
    • Baseline testing that is necessary

Joint Accreditation Statement

In support of improving patient care, Duke University Health System Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.


Physicians: Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.